Literature DB >> 24926083

Laboratory turnaround times in response to an abrupt increase in specimen testing after a natural disaster.

Kevin Taylor1, Peter George2, Joanne M Deely3.   

Abstract

OBJECTIVES: Understanding how key indicators change during extreme circumstances could help laboratories maintain high standards when responding to disasters. We assessed the effects of an earthquake on turnaround times (TATs) at a hospital laboratory.
METHODS: We examined TATs for 709,786 potassium tests and 196,795 urine cultures from February 2010 to January 2013. Hospital and community data were evaluated separately and compared during the transport, registration (accessioning), and analysis time phases.
RESULTS: After the earthquake, the laboratory undertook approximately 70% of the nonacute community specimen testing. Initially, community transport times increased by 20 to 27 hours and remained 2 to 3 hours above prequake levels. Registration time increased by 10 to 20 minutes (hospital) and 30 to 45 minutes (community) for a short period. During the initial few months, community urine culture analysis time increased by more than 50 hours.
CONCLUSIONS: The increase in specimen numbers affected short- and long-duration test TATs differently. Streamlining and automating processes reduced registration and analysis times. Increased transport time was outside the control of the laboratory. Copyright© by the American Society for Clinical Pathology.

Keywords:  Analysis time; Earthquake; Hospital laboratory; Potassium; Registration time; Transport time; Turnaround time; Urine cultures

Mesh:

Year:  2014        PMID: 24926083     DOI: 10.1309/AJCPIM9KKT2HVALL

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  1 in total

1.  The response of total testing process in clinical laboratory medicine to COVID-19
pandemic.

Authors:  Funda Eren; Merve Ergin Tuncay; Esra Firat Oguz; Salim Neselioglu; Ozcan Erel
Journal:  Biochem Med (Zagreb)       Date:  2021-06-15       Impact factor: 2.313

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.